Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Praxair (PX) Hits New 52-Week High On Solid Q1 & '17 View

Published 05/14/2017, 09:29 PM
Updated 07/09/2023, 06:31 AM

Shares of Praxair Inc. (NYSE:PX) reached a new 52-week high of $129.96 during its trading session on May 12. This apex improved upon the last 52-week high of $129.53 on May 5.

Post the release of first-quarter 2017 results on Apr 27, shares of the company yielded 3.38% return, as against 1.24% decline recorded by the Zacks categorized Chemicals Diversified industry.

On May 12, the company closed its trading session at $129.72, yielding year-to-date return of roughly 10.7%. The trading volume for the session was 1.1 million shares. Positive earnings estimate revisions for 2017 and 2018, along with an expected earnings growth rate of 12% for the next five years indicate the stock’s potential for further price appreciation.

Growth Drivers

Praxair’s financial performance was impressive in three of last four quarters, as evident from an average positive earnings surprise of 1.67%. In the first quarter, the company’s earnings of $1.37 per share surpassed the Zacks Consensus Estimate of $1.33 by 3.01%.

In 2017, Praxair anticipates benefiting from a talented workforce, sound product portfolio and new project wins. Base volume growth is predicted to be in sync with the prevailing macro conditions. Also, a solid backlog of $1.5 billion exiting the first quarter clearly reflects customers’ preference for the company’s world-class technology, high-quality products and gas supply services.

The company increased the lower-end of its previous guidance range of $5.45–$5.80 per share by 10 cents to $5.55–$5.80. Excluding 1% negative impact of foreign currency headwinds, earnings are predicted to grow 2–7% year over year. For the second quarter, the company expects earnings in the range of $1.38–$1.43 per share.

Estimate Revisions Show Potency

Over the last 30 days, the Zacks Consensus Estimate for Praxair increased 0.2% to $5.73 for 2017 and 0.2% to $6.26 for 2018. Also, these estimates represent year-over-year growth of 4.5% for 2017 and 9.4% for 2018.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Praxair, Inc. Price and Consensus

Praxair, Inc. Price and Consensus | Praxair, Inc. Quote

With a market capitalization of $37 billion, Praxair currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the chemicals industry include Huntsman Corporation (NYSE:HUN) , Kronos Worldwide Inc (NYSE:KRO) and BASF SE (OTC:BASFY) , each boasting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Huntsman Corporation’s earnings estimates for 2017 and 2018 were revised upward over the last 60 days. Also, its average earnings surprise for the last four quarters was a positive 20.12%.

Kronos Worldwide’s financial performance in three out of last four quarters was impressive, with an average positive earnings surprise of 64.14%. Also, its earnings estimates for 2017 improved over the last 60 days.

BASF SE’s average earnings surprise for the last four quarters was a positive 3.02%. Also, its earnings estimates for 2017 and 2018 improved in the last 60 days.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>



BASF SE (BASFY): Free Stock Analysis Report

Praxair, Inc. (PX): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Huntsman Corporation (HUN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.